First-in-human study of CH5132799, an oral class I PI3K inhibitor, studying toxicity, pharmacokinetics, and pharmacodynamics, in patients with metastatic cancer. (Record no. 24200196)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02274 a2200637 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516233615.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201507s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1557-3265 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1158/1078-0432.CCR-14-1315 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Blagden, Sarah |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20150728 |
| 245 00 - TITLE STATEMENT | |
| Title | First-in-human study of CH5132799, an oral class I PI3K inhibitor, studying toxicity, pharmacokinetics, and pharmacodynamics, in patients with metastatic cancer. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Clinical cancer research : an official journal of the American Association for Cancer Research |
| Date of publication, distribution, etc. | Dec 2014 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 5908-17 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Administration, Oral |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Class I Phosphatidylinositol 3-Kinases |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dose-Response Relationship, Drug |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Maximum Tolerated Dose |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasm Metastasis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasms |
| General subdivision | diagnosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Positron-Emission Tomography |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pyrimidines |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sulfonamides |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tomography, X-Ray Computed |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Omlin, Aurelius |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Olmin, Aurelius |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Josephs, Debra |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Stavraka, Chara |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zivi, Andrea |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pinato, David J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Anthoney, Alan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Decordova, Shaun |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Swales, Karen |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Riisnaes, Ruth |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pope, Lorna |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Noguchi, Kohei |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shiokawa, Rie |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Inatani, Michiyasu |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Prince, Jenny |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jones, Keith |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Twelves, Chris |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Spicer, James |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Banerji, Udai |
| 773 0# - HOST ITEM ENTRY | |
| Title | Clinical cancer research : an official journal of the American Association for Cancer Research |
| Related parts | vol. 20 |
| -- | no. 23 |
| -- | p. 5908-17 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1158/1078-0432.CCR-14-1315">https://doi.org/10.1158/1078-0432.CCR-14-1315</a> |
| Public note | Available from publisher's website |
No items available.